Today, two major US companies associated with the medical-insurance (UnitedHealth) and medical (Johnson&Johnson) markets reported financial results for Q1 2024. Both companies reported higher-than-expected earnings, but it was UnitedHealth's (UNH.US) report that came as the bigger positive surprise, while Johnson&Johnson's (JNJ.US) results suggest lower demand in the MedTech sector. Both companies are listed members of the Dow Jones Industrial Average (DIJA) index.
UnitedHealth with a positive surprise
Despite the February 2024 cyber-attack, the company expects to achieve its previously set annual sales targets, to which the market reacted optimistically. Shares are gaining more than 4% in the pre-market. Revenues rose almost 9% from $91.9bn in Q1 2023 to $99.8bn in Q1 2024. Adjusted earnings per share came in at US$6.91 against US$6.61 forecasts.
- The negative currency effect from the sale of the company's Brazil unit and the cyberattack weakened earnings per share by US$1.53 (US$0.74 due to the cyberattack and expected from US$1.15 - US$1.35 for the full year horizon). MCR was 84.3% compared to 83.8% expected on Wall Street, indicating a continuing problem with achieving full profitability.
- Pharmaceutical services sales and consulting at the Optum unit (103m customers) were $61.1bn vs $54.1bn in Q1 .2023. Medical services sales offered at UnitedHealthCare were $75.3bn vs $70.5bn in Q1 .2023, the company indicated, driven by healthy private client growth (up 2m in Q1 .2024). The company expects adjusted earnings per share of US$27.5 to US$28 in 2024.
United Health (UNH.US) chart, D1 interval
Source: xStation5
Johnson&Johnson's adjusted EPS came in at US$2.71 against US$2.65, and sales of US$21.38bn came in marginally lower than the US$21.39bn forecast. Medical technology sales came in at US$7.82bn against US$7.94bn expectations, and the company's full-year sales estimates are now oscillating between US$88bn and US$88.4bn, indicating that the company expects a slight improvement in revenue, in future quarters. The company's shares are trading flat ahead of the US market open.
Johnson&Johnson (JNJ.US) chart, D1 interval
Source: xStation5
شركات التكنولوجيا الكبرى تدعم قائمة أفضل 100 شركة أمريكية 📈 مايكروسوفت، وتسلا، وميتا بلاتفورمز تنشر نتائج الربع الرابع!
الولايات المتحدة: أعلى مستوى تاريخي قبل اجتماع الاحتياطي الفيدرالي
ما الذي يمكن توقعه من نتائج شركة ميتا للربع الرابع من عام 2025؟ الإعلانات، والذكاء الاصطناعي، وثمن النمو السريع
ارتفاع أسهم ستاربكس بعد إعلان أرباح الربع الرابع وسط انتعاش السوق الأمريكية 📈
